VSNL1 Co-Expression Networks in Aging Include Calcium Signaling, Synaptic Plasticity, and Alzheimer's Disease Pathways

• Published in: Frontiers in psychiatry Vol. 6; p. 30
• Main Authors: Lin, Chien-Wei, Chang, Lun-Ching, Tseng, George C, Kirkwood, Caitlin M, Sibille, Etienne L, Sweet, Robert A
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 2015
• Subjects: Alzheimer disease (AD); Calcium Signaling; co-expression networks; Psychiatry; synaptic plasticity; Visinin-like 1 (VSNL1); Visinin-like protein 1 (VILIP1); visinin-like 1; visinin-like protein 1; co-expression networks; synaptic plasticity; Alzheimer disease; calcium signaling
• ISSN: 1664-0640; 1664-0640
• DOI: 10.3389/fpsyt.2015.00030

The visinin-like 1 (VSNL1) gene encodes visinin-like protein 1, a peripheral biomarker for Alzheimer disease (AD). Little is known, however, about normal VSNL1 expression in brain and the biologic networks in which it participates. Frontal cortex gray matter obtained from 209 subjects without neurodegenerative or psychiatric illness, ranging in age from 16 to 91, was processed on Affymetrix GeneChip 1.1 ST and Human SNP Array 6.0. VSNL1 expression was unaffected by age and sex, and not significantly associated with SNPs in cis or trans. VSNL1 was significantly co-expressed with genes in pathways for calcium signaling, AD, long-term potentiation, long-term depression, and trafficking of AMPA receptors. The association with AD was driven, in part, by correlation with amyloid precursor protein (APP) expression. These findings provide an unbiased link between VSNL1 and molecular mechanisms of AD, including pathways implicated in synaptic pathology in AD. Whether APP may drive increased VSNL1 expression, VSNL1 drives increased APP expression, or both are downstream of common pathogenic regulators will need to be evaluated in model systems.